Cargando…

Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta

BACKGROUND: It is well established that obesity is associated with dysregulation of the ratio between the two major adipokines leptin and adiponectin. Furthermore, it was recently reported that maternal obesity has a significant impact on placental development. Leptin and adiponectin are present at...

Descripción completa

Detalles Bibliográficos
Autores principales: Nogues, Perrine, Dos Santos, Esther, Jammes, Hélène, Berveiller, Paul, Arnould, Lucie, Vialard, François, Dieudonné, Marie-Noëlle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367801/
https://www.ncbi.nlm.nih.gov/pubmed/30732639
http://dx.doi.org/10.1186/s13148-019-0612-6
_version_ 1783393875481591808
author Nogues, Perrine
Dos Santos, Esther
Jammes, Hélène
Berveiller, Paul
Arnould, Lucie
Vialard, François
Dieudonné, Marie-Noëlle
author_facet Nogues, Perrine
Dos Santos, Esther
Jammes, Hélène
Berveiller, Paul
Arnould, Lucie
Vialard, François
Dieudonné, Marie-Noëlle
author_sort Nogues, Perrine
collection PubMed
description BACKGROUND: It is well established that obesity is associated with dysregulation of the ratio between the two major adipokines leptin and adiponectin. Furthermore, it was recently reported that maternal obesity has a significant impact on placental development. Leptin and adiponectin are present at the fetal-maternal interface and are involved in the development of a functional placenta. However, less is known about leptin and adiponectin’s involvement in the placental alterations described in obese women. Hence, the objective of the present study was to characterize the placental expression and DNA methylation of these two adipokine systems (ligands and receptors) in obese women. RESULTS: Biopsies were collected from the fetal and maternal sides of third-trimester placenta in obese and non-obese (control) women. In both groups, leptin levels were higher on the fetal side than the maternal side, suggesting that this cytokine has a pivotal role in fetal growth. Secondly, maternal obesity (in the absence of gestational diabetes) was associated with (i) elevated DNA methylation of the leptin promoter on fetal side only, (ii) hypomethylation of the adiponectin promoter on the maternal side only, (iii) significantly low levels of leptin receptor protein (albeit in the absence of differences in mRNA levels and promoter DNA methylation), (iv) significantly low levels of adiponectin receptor 1 mRNA expression on the maternal side only, and (v) elevated DNA methylation of the adiponectin receptor 2 promoter on the maternal side only. CONCLUSION: Our present results showed that maternal obesity is associated with the downregulation of both leptin/adiponectin systems in term placenta, and thus a loss of the beneficial effects of these two adipokines on placental development. Maternal obesity was also associated with epigenetic changes in leptin and adiponectin systems; this highlighted the molecular mechanisms involved in the placenta’s adaptation to a harmful maternal environment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-019-0612-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6367801
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63678012019-02-15 Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta Nogues, Perrine Dos Santos, Esther Jammes, Hélène Berveiller, Paul Arnould, Lucie Vialard, François Dieudonné, Marie-Noëlle Clin Epigenetics Research BACKGROUND: It is well established that obesity is associated with dysregulation of the ratio between the two major adipokines leptin and adiponectin. Furthermore, it was recently reported that maternal obesity has a significant impact on placental development. Leptin and adiponectin are present at the fetal-maternal interface and are involved in the development of a functional placenta. However, less is known about leptin and adiponectin’s involvement in the placental alterations described in obese women. Hence, the objective of the present study was to characterize the placental expression and DNA methylation of these two adipokine systems (ligands and receptors) in obese women. RESULTS: Biopsies were collected from the fetal and maternal sides of third-trimester placenta in obese and non-obese (control) women. In both groups, leptin levels were higher on the fetal side than the maternal side, suggesting that this cytokine has a pivotal role in fetal growth. Secondly, maternal obesity (in the absence of gestational diabetes) was associated with (i) elevated DNA methylation of the leptin promoter on fetal side only, (ii) hypomethylation of the adiponectin promoter on the maternal side only, (iii) significantly low levels of leptin receptor protein (albeit in the absence of differences in mRNA levels and promoter DNA methylation), (iv) significantly low levels of adiponectin receptor 1 mRNA expression on the maternal side only, and (v) elevated DNA methylation of the adiponectin receptor 2 promoter on the maternal side only. CONCLUSION: Our present results showed that maternal obesity is associated with the downregulation of both leptin/adiponectin systems in term placenta, and thus a loss of the beneficial effects of these two adipokines on placental development. Maternal obesity was also associated with epigenetic changes in leptin and adiponectin systems; this highlighted the molecular mechanisms involved in the placenta’s adaptation to a harmful maternal environment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-019-0612-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-07 /pmc/articles/PMC6367801/ /pubmed/30732639 http://dx.doi.org/10.1186/s13148-019-0612-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Nogues, Perrine
Dos Santos, Esther
Jammes, Hélène
Berveiller, Paul
Arnould, Lucie
Vialard, François
Dieudonné, Marie-Noëlle
Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta
title Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta
title_full Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta
title_fullStr Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta
title_full_unstemmed Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta
title_short Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta
title_sort maternal obesity influences expression and dna methylation of the adiponectin and leptin systems in human third-trimester placenta
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367801/
https://www.ncbi.nlm.nih.gov/pubmed/30732639
http://dx.doi.org/10.1186/s13148-019-0612-6
work_keys_str_mv AT noguesperrine maternalobesityinfluencesexpressionanddnamethylationoftheadiponectinandleptinsystemsinhumanthirdtrimesterplacenta
AT dossantosesther maternalobesityinfluencesexpressionanddnamethylationoftheadiponectinandleptinsystemsinhumanthirdtrimesterplacenta
AT jammeshelene maternalobesityinfluencesexpressionanddnamethylationoftheadiponectinandleptinsystemsinhumanthirdtrimesterplacenta
AT berveillerpaul maternalobesityinfluencesexpressionanddnamethylationoftheadiponectinandleptinsystemsinhumanthirdtrimesterplacenta
AT arnouldlucie maternalobesityinfluencesexpressionanddnamethylationoftheadiponectinandleptinsystemsinhumanthirdtrimesterplacenta
AT vialardfrancois maternalobesityinfluencesexpressionanddnamethylationoftheadiponectinandleptinsystemsinhumanthirdtrimesterplacenta
AT dieudonnemarienoelle maternalobesityinfluencesexpressionanddnamethylationoftheadiponectinandleptinsystemsinhumanthirdtrimesterplacenta